Parkwood »

Vor Biopharma shares owned by Parkwood

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Parkwood

Quarter filed Position value Share count Share price at filing
2023-06-30 $228k 74k 3.08
2023-03-31 $117k 22k 5.38
2021-12-31 $458k 39k 11.63
2021-09-30 $774k 49k 15.69
2021-06-30 $946k 51k 18.65

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Etp (VTI)
Ishares Russell 2000 Etf Etp Put Option (IWM)
Spdr S&p 500 Etf Trust Etp Put Option (SPY)
Spdr Bloomberg 1-3 Month T-b Etp (BIL)
Kraneshares Csi China Intern Etp Call Option (KWEB)
Ishares 20 Year Treasury Bo Etp Call Option (TLT)
Roblox Corp -class A Common Stock (RBLX)
Vanguard Ftse Emerging Marke Etp (VWO)
Ark Innovation Etf Etp (ARKK)
Totalenergies Se - Adr (TTE)
Elevance Health Common Stock (ELV)
Canadian Natural Resources Common Stock (CNQ)
Vanguard Tot World Stk Etf Etp (VT)
Apollo Global Management Common Stock (APO)
Novo-nordisk A/s-spons Adr (NVO)

View all positions for Parkwood

Top funds holding Vor Biopharma

RA Capital Management
Paradigm Biocapital Advisors
5AM Venture Management
Laurion Capital Management
Artal Group
Vanguard Group
Sarissa Capital Management
MAI Wealth Advisors
Exchange Traded Concepts
Bank of New York Mellon
Charles Schwab Investment Management
Bank of America Corporation
Barclays
LMR Partners
Rhumbline Advisers

View all funds holding Vor Biopharma